154598-52-4 Efavirenz AKSci E140
 
 
Loading Please Wait...
  E140    
Efavirenz
, 98% (HPLC)
 
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one, Efavirenz
Stocrin
Sustiva




IDENTITY
CAS Number:154598-52-4
MDL Number:MFCD05662344
MF:C14H9ClF3NO2
MW:315.67
SPECIFICATIONS & PROPERTIES
Purity:98% (HPLC)
Physical Form:White to off-white to beige powder
Melting Point:137-141°C
Optical Rotation:-86.0 - -96.0° (c=1, MeOH)
Long-Term Storage:Store long-term at -20°C

BIOLOGICAL INFO
Solubility:DMSO: 15 mg/mL, clear
Application(s):Non-nucleoside reverse transcriptase inhibitor (NNRTI)

REVIEW

 Efavirenz is a chiral, single enantiomer non-nucleoside reverse transcriptase inhibitor (NNRTI). Similar to zidovudine, efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV type I from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated efavirenz, this action may nevertheless account for some of the drug''s toxicity.

REFERENCES
[1]Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK: Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14410-5. Epub 2002 Oct 17.
[2] Young, Steven D.; Tran, Lekhanh O.; Britcher, Susan F.; Lumma, William C., Jr.; Payne, Linda S.Preparation of benzoxazinones as inhibitors of HIV reverse transcriptase Eur. Pat. Appl. (1994), EP 582455 A1 19940209.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H400

Precautionary Statements
P273


Current as of November 21, 2019


Download SDS

For research use only. Not for diagnostic or therapeutic use.
Not for human use.


CATEGORIES

 APIs and Bioactives > Antivirals;NNRTIs


PubChem